We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published

News   May 08, 2015

 
Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published
 
 
Advertisement
 

RELATED ARTICLES

A New Realm of Drug Discovery Utilizing Ubiquitin Ligase

News

UNLV scientist Gary Kleiger is at the forefront of a potential new drug modality; research published in the journal Nature.

READ MORE

Watching Nanoparticles Get in Shape

News

Real-time high-resolution videos have been captured by researchers showing liquid structures taking shape as nanoparticle surfactants (NPSs). The soap-like particles jam tightly together, side by side, to form a solid-like layer at the interface between oil and water.

READ MORE

A Gene Serves Both a Protective and Destructive Role in Health

News

Researchers suggest that the gene ENDU-2 could be responsible for triggering tumors in the body. The team discovered that while under stress, ENDU-2 can contribute both to the protection of the organism and to its destruction.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE